Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Greater Cannabis Company (GCAN) Accumulated Expenses (2016 - 2026)

Greater Cannabis Company has reported Accumulated Expenses over the past 7 years, most recently at $263000.0 for Q4 2022.

  • For Q4 2022, Accumulated Expenses rose 1345.13% year-over-year to $263000.0; the TTM value through Dec 2022 reached $263000.0, up 1345.13%, while the annual FY2022 figure was $263000.0, 1345.13% up from the prior year.
  • Accumulated Expenses for Q4 2022 was $263000.0 at Greater Cannabis Company, up from $233000.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $263000.0 in Q4 2022 and troughed at $814.0 in Q1 2021.
  • A 5-year average of $47185.1 and a median of $16105.0 in 2018 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: plummeted 93.1% in 2021 and later surged 28524.08% in 2022.
  • Year by year, Accumulated Expenses stood at $85000.0 in 2018, then crashed by 41.18% to $50000.0 in 2019, then tumbled by 66.3% to $16849.0 in 2020, then rose by 8.01% to $18199.0 in 2021, then surged by 1345.13% to $263000.0 in 2022.
  • Business Quant data shows Accumulated Expenses for GCAN at $263000.0 in Q4 2022, $233000.0 in Q1 2022, and $18199.0 in Q4 2021.